Skip to content
Catalyst

PapersPMID:33201232

Effects of α-Cyclodextrin on Cholesterol Control and Hydrolyzed Ginseng Extract on Glycemic Control in People With Prediabetes: A Randomized Clinical Trial.

JAMA network open2020The record ↗

  1. Finding, moderate evidencelowersBody mass index

What moved

1 findingHow to read these marks →
  • “This effect of HGE on weight was not observed in the ITT (−0.59 kg; 95% CI, −1.47 to 0.29 kg; P =.19) (Table 4) or completers analysis (−0.54 kg; 95% CI, −1.45 to 0.38 kg; P =.25) (eTable 4 in Supplement 2) but in the ITT analysis, participants taking HGE had a significantly lower BMI than participants taking placebo at 6 months (−0.32; 95% CI, −0.63 to −0.02; P =.04) (Table 4).”
    Study
    RCT
    Duration
    6 months
    Dose studied
    160 mg HGE per capsule, 2 capsules before each of breakfast, lunch and dinner, 6 months
    Population
    Adults aged 18 or older with prediabetes and overweight or obesity (BMI 25 or higher), in a 2 x 2 factorial trial in which alpha-cyclodextrin or its placebo was given equally across the hydrolyzed ginseng and placebo comparison; all participants received dietetic advice for weight loss; intention-to-treat analysis

Study record

Design
randomised controlled trial
Species
human
Population
Adults with prediabetes and BMI 25 or higher; 2 x 2 factorial of alpha-cyclodextrin and hydrolyzed ginseng extract (HGE; ginseng species not named in the text read)
Participants
401
Comparator
placebo
Duration
183 days
Endpoints measured
31